Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2

Biochemical and Biophysical Research Communications

Volumn 383, Issue 2, 2009, Pages 198-202

  Schmidt, Karyn ^a   Wolfe, Devin M ^a   Stiller, Barbara ^b   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

ATP13A2; Kufor Rakeb syndrome; Parkinsonism; YPK9

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 13A2; CADMIUM; HISTIDINE; MANGANESE; NICKEL; SELENIUM; UNCLASSIFIED DRUG; ATP13A2 PROTEIN, HUMAN; DIVALENT CATION; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SACCHAROMYCES CEREVISIAE PROTEIN; YPK9 PROTEIN, S CEREVISIAE;

AMINO ACID METABOLISM; AMINO ACID SEQUENCE; ARTICLE; FUNGAL GENE; FUNGUS GROWTH; GENE DELETION; GENE LOCATION; LYSOSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YPK9 GENE; CELL VACUOLE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM;

SACCHAROMYCES CEREVISIAE;

CADMIUM; CATIONS, DIVALENT; HISTIDINE; HUMANS; MANGANESE; NICKEL; PROTON-TRANSLOCATING ATPASES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SELENIUM; VACUOLES;

EID: 65049087704     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.151     Document Type: Article

References (47)

1. Adle D.J., and Lee J. Expressional control of a cadmium-transporting P1B-type ATPase by a metal sensing degradation signal. J. Biol. Chem. 283 (2008) 31460-31468
2. Aguilar M.V., Jimenez-Jimenez F.J., Molina J.A., Meseguer I., Mateos-Vega C.J., Gonzalez-Munoz M.J., de Bustos F., Gomez-Escalonilla C., Ort-Pareja M., Zurdo M., and Martinez-Para M.C. Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease. J. Neural Transm. 105 (1998) 1245-1251
3. al-Din S.N., Anderson M., Eeg-Olofsson O., and Trontelj J.V. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol. Scand. 89 (1994) 157-163
4. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 Suppl. (2004) S18-S25
5. Axelsen K.B., and Palmgren M.G. Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 46 (1998) 84-101
6. 2 and thiol-reactive chemicals signaling. Free Radic. Biol. Med. 35 (2003) 889-900
7. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004) 205-214
8. Bressler J.P., Olivi L., Cheong J.H., Kim Y., and Bannona D. Divalent metal transporter 1 in lead and cadmium transport. Ann. N.Y. Acad. Sci. 1012 (2004) 142-152
9. Castano A., Cano J., and Machado A. Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum. J. Neurochem. 61 (1993) 1302-1307
10. Dalton T.P., He L., Wang B., Miller M.L., Jin L., Stringer K.F., Chang X., Baxter C.S., and Nebert D.W. Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. Proc. Natl. Acad. Sci. USA 102 (2005) 3401-3406
11. Das K.K., Das S.N., and Dhundasi S.A. Nickel, its adverse health effects & oxidative stress. Indian J. Med. Res. 128 (2008) 412-425
12. Davison C. Pallido-pyramidal disease. J. Neuropathol. Exp. Neurol. 13 (1954) 50-59
13. Delaunay A., Pflieger D., Barrault M.B., Vinh J., and Toledano M.B. A thiol peroxidase is an H2O2 receptor and redox-transducer in gene activation. Cell 111 (2002) 471-481
14. Di Fonzo A., Chien H.F., Socal M., Giraudo S., Tassorelli C., Iliceto G., Fabbrini G., Marconi R., Fincati E., Abbruzzese G., Marini P., Squitieri F., Horstink M.W., Montagna P., Libera A.D., Stocchi F., Goldwurm S., Ferreira J.J., Meco G., Martignoni E., Lopiano L., Jardim L.B., Oostra B.A., Barbosa E.R., and Bonifati V. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68 (2007) 1557-1562
15. Ercal N., Gurer-Orhan H., and Aykin-Burns N. Toxic metals and oxidative stress. Part I. Mechanisms involved in metal-induced oxidative damage. Curr. Top. Med. Chem. 1 (2001) 529-539
16. 2+ in Saccharomyces cerevisiae cells. Biosci. Biotechnol. Biochem. 69 (2005) 2343-2348
17. Gharieb M.M., and Gadd G.M. Evidence for the involvement of vacuolar activity in metal(loid) tolerance: vacuolar-lacking and -defective mutants of Saccharomyces cerevisiae display higher sensitivity to chromate, tellurite and selenite. Biometals 11 (1998) 101-106
18. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., and Lindquist S. alpha-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41 (2009) 308-315
19. Gomes D.S., Fragoso L.C., Riger C.J., Panek A.D., and Eleutherio E.C. Regulation of cadmium uptake by Saccharomyces cerevisiae. Biochim. Biophys. Acta 1573 (2002) 21-25
20. Huang K., Lauridsen E., and Clausen J. The uptake of Na-selenite in rat brain. Localization of new glutathione peroxidases in the rat brain. Biol. Trace Elem. Res. 46 (1994) 91-102
21. Huh W.K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., Weissman J.S., and O'Shea E.K. Global analysis of protein localization in budding yeast. Nature 425 (2003) 686-691
22. Hunt R.H. Correspondence. Calif. State J. Med. 15 (1917) 474-475
23. Ito H., Fukuda Y., Murata K., and Kimura A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153 (1983) 163-168
24. Jankovic J. Parkinsonism-plus syndromes. Mov. Disord. 4 Suppl. 1 (1989) S95-S119
25. Jarup L., Berglund M., Elinder C.G., Nordberg G., and Vahter M. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand. J. Work Environ. Health 24 Suppl. 1 (1998) 1-51
26. Kuhlbrandt W. Biology, structure and mechanism of P-type ATPases. Nat. Rev. Mol. Cell. Biol. 5 (2004) 282-295
27. Lapinskas P.J., Lin S.J., and Culotta V.C. The role of the Saccharomyces cerevisiae CCC1 gene in the homeostasis of manganese ions. Mol. Microbiol. 21 (1996) 519-528
28. Leslie E.M., Liu J., Klaassen C.D., and Waalkes M.P. Acquired cadmium resistance in metallothionein-I/II(-/-) knockout cells: role of the T-type calcium channel Cacnalpha1G in cadmium uptake. Mol. Pharmacol. 69 (2006) 629-639
29. Li N.Q., Reddy P.S., Thyagaraju K., Reddy A.P., Hsu B.L., Scholz R.W., Tu C.P., and Reddy C.C. Elevation of rat liver mRNA for selenium-dependent glutathione peroxidase by selenium deficiency. J. Biol. Chem. 265 (1990) 108-113
30. Lin C.H., Tan E.K., Chen M.L., Tan L.C., Lim H.Q., Chen G.S., and Wu R.M. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology 71 (2008) 1727-1732
31. Luk E., Yang M., Jensen L.T., Bourbonnais Y., and Culotta V.C. Manganese activation of superoxide dismutase 2 in the mitochondria of Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 22715-22720
32. Miccadei S., and Floridi A. Sites of inhibition of mitochondrial electron transport by cadmium. Chem. Biol. Interact. 89 (1993) 159-167
33. Moller A.B., Asp T., Holm P.B., and Palmgren M.G. Phylogenetic analysis of P5 P-type ATPases, a eukaryotic lineage of secretory pathway pumps. Mol. Phylogenet. Evol. 46 (2008) 619-634
34. Nisipeanu P., Kuritzky A., and Korczyn A.D. Familial levodopa-responsive parkinsonian-pyramidal syndrome. Mov. Disord. 9 (1994) 673-675
35. Pearce D.A., and Sherman F. Toxicity of copper, cobalt, and nickel salts is dependent on histidine metabolism in the yeast Saccharomyces cerevisiae. J. Bacteriol. 181 (1999) 4774-4779
36. Perfus-Barbeoch L., Leonhardt N., Vavasseur A., and Forestier C. Heavy metal toxicity: cadmium permeates through calcium channels and disturbs the plant water status. Plant J. 32 (2002) 539-548
37. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., Al-Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., and Kubisch C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38 (2006) 1184-1191
38. Ravindranath S.D., and Fridovich I. Isolation and characterization of a manganese-containing superoxide dismutase from yeast. J. Biol. Chem. 250 (1975) 6107-6112
39. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., and Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
40. Schiestl R.H., and Gietz R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16 (1989) 339-346
41. Tandogan B., and Ulusu N.N. The inhibition kinetics of yeast glutathione reductase by some metal ions. J. Enzyme Inhib. Med. Chem. 22 (2007) 489-495
42. Vida T.A., and Emr S.D. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J. Cell Biol. 128 (1995) 779-792
43. Wang Y., Fang J., Leonard S.S., and Rao K.M. Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med. 36 (2004) 1434-1443
44. Weisiger R.A., and Fridovich I. Mitochondrial superoxide dismutase. Site of synthesis and intramitochondrial localization. J. Biol. Chem. 248 (1973) 4793-4796
45. Williams D.R., Hadeed A., al-Din A.S., Wreikat A.L., and Lees A.J. Kufor-Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov. Disord. 20 (2005) 1264-1271
46. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Salim S., and Islam F. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J. Neurochem. 84 (2003) 438-446
47. Zecca L., Youdim M.B., Riederer P., Connor J.R., and Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5 (2004) 863-873